WuXi Biologics starts strong on $510m HK IPO
WuXi Biologics’ HK$3.9bn ($510.4m) IPO is off to a resounding start, with books multiple times covered within hours of opening on Thursday, according to bankers close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: